Correlation Between Tscan Therapeutics and Apexigen
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Apexigen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Apexigen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Apexigen, you can compare the effects of market volatilities on Tscan Therapeutics and Apexigen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Apexigen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Apexigen.
Diversification Opportunities for Tscan Therapeutics and Apexigen
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tscan and Apexigen is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Apexigen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apexigen and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Apexigen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apexigen has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Apexigen go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Apexigen
If you would invest 39.00 in Apexigen on January 31, 2024 and sell it today you would earn a total of 0.00 from holding Apexigen or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 4.55% |
Values | Daily Returns |
Tscan Therapeutics vs. Apexigen
Performance |
Timeline |
Tscan Therapeutics |
Apexigen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Tscan Therapeutics and Apexigen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tscan Therapeutics and Apexigen
The main advantage of trading using opposite Tscan Therapeutics and Apexigen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Apexigen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apexigen will offset losses from the drop in Apexigen's long position.Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos TherapeuticsInc | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Apexigen vs. Leap Therapeutics | Apexigen vs. Zura Bio Limited | Apexigen vs. X4 Pharmaceuticals | Apexigen vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |